Showing results (1241-1250 of 1,289) with videos related to

Sort By:
Pageof 129
Research Integrity and Peer Review|November 16, 2025
Research methodology education in Europe: a multi-country, cross-disciplinary survey of current practices and perspectivesSilke Kniffert, Ivan Buljan, Flavio Azevedo, et al.
Antimicrobial Resistance and Infection Control|January 4, 2019
Incidence of infections due to third generation cephalosporin-resistant Enterobacteriaceae - a prospective multicentre cohort study in six German university hospitalsAnna M Rohde, Janine Zweigner, Miriam Wiese-Posselt, et al.
Bioorganic & Medicinal Chemistry|September 1, 2000
Antimicrobial effects of novel siderophores linked to beta-lactam antibioticsT Kline, M Fromhold, T E McKennon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 10, 2023
MET Fusions in NSCLC: Clinicopathologic Features and Response to MET InhibitionRichard Riedel, Jana Fassunke, Andreas H Scheel, et al.
International Journal of Environmental Research and Public Health|April 30, 2021
Accelerometer-Measured Daily Step Counts and Adiposity Indicators among Latin American Adults: A Multi-Country StudyGerson Ferrari, Adilson Marques, Tiago V Barreira, et al.
Lung Cancer (Amsterdam, Netherlands)|May 4, 2020
Co-occurrence of targetable mutations in Non-small cell lung cancer (NSCLC) patients harboring MAP2K1 mutationsMatthias Scheffler, Alessandra Holzem, Anna Kron, et al.
Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy|June 4, 2020
A novel endoimaging system for endoscopic 3D reconstruction in bladder cancer patientsRodrigo Suarez-Ibarrola, Maximilian Kriegmair, Frank Waldbillig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2025
Molecular and clinical characteristics of patients with non-small cell lung cancer (NSCLC) harboring KRAS G12V mutationsFelix John, Lea Ruge, Malte Verheyen, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1996
Nonpeptide glycoprotein IIb/IIIa inhibitors. 8. Antiplatelet activity and oral antithrombotic efficacy of L-734,217J J Cook, M A Holahan, E A Lyle, et al.
Pageof 129